Search results
Found 14 matches for
Many congratulations to Prof Adrian Harris (Department of Oncology), who has become a Fellow of the Association of Cancer Physicians.
Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases
MRC TIDU NDCN RDM
11 January 2024
New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy
MRC HIU NDCN
29 July 2022
The paper, published in Nature Communications reveals key genes involved in the common developmental disease.
Seven research groups secure LEAF Sustainability Awards
Department of Oncology MRC HIU MRC MHU NDCN RDM
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.
Spatial transcriptomics of neurodegeneration in Progressive Multiple Sclerosis (MS)
MRC HIU NDCN
28 June 2022
In a paper published in Nature Neuroscience, the Fugger Group describe molecular pathways of MS neurodegeneration in unprecedented detail.
Funding awarded for autoimmune disease research
MRC HIU NDCN
13 May 2022
Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis
NDCN
16 February 2021
MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.
Angela Vincent honoured for excellence in epilepsy research
NDCN
17 December 2019
Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.
New research to investigate role of blood-brain barrier
NDCN
12 February 2019
A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.
European licence for migraine prevention drug
NDCN
31 July 2018
MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines
World’s largest autism grant will transform research landscape
NDCN
18 June 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.
Oxford Centre for Neuroinflammation launched
MRC HIU NDCN
30 May 2018
The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
Prof David Beeson elected Fellow of the Academy of Medical Sciences
NDCN
10 May 2018
Many congratulations to Prof Beeson for this distinction recognising his exceptional contribution to the study of neuromuscular disorders.
MRC WIMM researchers talk about their research on rare diseases
Department of Oncology MRC MHU NDCN RDM
28 February 2018
To mark rare disease day we asked our researchers to tell us more about the rare conditions that they study, and why their research is important.